| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.5B | $4.0B | $3.8B | $3.4B | $0.8B | $0.6B | $0.7B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.0B | $1.8B | $1.7B | $1.4B | $0.3B | $0.3B | $0.3B | $0.3B |
| Net Income | $1.1B | $1.0B | $1.0B | $1.0B | $0.2B | $0.2B | $0.2B | $0.3B |
| EPS (Basic) | $15.23 | $14.27 | $13.42 | $12.62 | $2.80 | $2.51 | $2.72 | $3.45 |
| EPS (Diluted) | $15.03 | $13.97 | $13.20 | $12.42 | $2.74 | $2.44 | $2.60 | $3.33 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.4B | $18.0B | $15.5B | $14.1B | $13.4B | $11.2B | $12.2B | $11.2B |
| Current Assets | $14.0B | $8.7B | $7.1B | $6.1B | $5.5B | $4.0B | $4.6B | $3.9B |
| Cash & Equivalents | $2.4B | $1.6B | $1.4B | $1.4B | $1.5B | $0.9B | $1.3B | $1.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $14.3B | $8.7B | $6.8B | $6.0B | $5.3B | $4.0B | $4.5B | $4.5B |
| Stockholders' Equity | $3.9B | $3.1B | $3.3B | $2.5B | $2.9B | $3.4B | $3.7B | $3.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.9B | $2.1B | $0.8B | $1.2B | $1.5B | $1.2B | $0.9B |
| Investing Cash Flow | $1.2B | $-0.8B | $-0.4B | $-0.4B | $-0.7B | $-0.1B | $-0.5B | $-0.0B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $1.6B | $0.4B | $-0.9B | $-0.3B | $0.3B | $-1.4B | $-0.3B | $-0.6B |